Nitric oxide and nitroxidative stress in Alzheimer's disease
Abstract
Nitric oxide is a signaling molecule produced by neurons and endothelial cells in the brain. NO is synthesized from L-arginine and oxygen by nitric oxide synthase: neuronal (nNOS), endothelial (eNOS), and inducible (iNOS). The endothelial NO acts as a vasorelaxant in the vasculature and as a neurotransmitter when produced by neurons (under the pathological conditions of Alzheimer's disease). NO can be scavenged in a rapid reaction with superoxide (O2-) to generate peroxynitrite (ONOO-), with a half-life of < 1 s. ONOO- is a potent oxidant and the primary component of nitroxidative stress. At high concentrations (> 100 nM), ONOO- can undergo homolytic or heterolytic cleavage to produce NO2+, NO2, and OH., highly reactive oxidative species and secondary components of nitroxidative stress. The high nitroxidative stress can initiate a cascade of redox reactions which can trigger apoptosis and evoke cytotoxic effects on neurons and endothelial cells. This article reviews the functions of NO and the potential role of NO/O2-/ONOO- induced nitroxidative stress in neuronal and endothelial degeneration observed in Alzheimer's disease.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The primary reactive species detected in our paradigm was ONOO−.
“Given the sensitivity of CM-H2DCFDA to oxidation by ONOO−, in combination with the propensity of ONOO− formation attributable to Aβ-induced stress, we reasoned that the primary RS detected in our paradigm was ONOO− (Setsukinai et al., 2003; Malinski, 2007).”
From The mitochondria-targeted antioxidant MitoQ prevents loss of spatial memory retention and early neuropathology in a transgenic mouse model of Alzheimer’s disease (2011) · cites this paper as Malinski, 2007
Tyrosine nitration provides a footprint for free radical-mediated damage involving oxidation of NO· to ONOO− or products of its subsequent decomposition and the formation of a tyrosyl radical intermediate.
“Tyrosine nitration provides a footprint for free radical-mediated damage involving oxidation of NO· to ONOO− or products of its subsequent decomposition and the formation of a tyrosyl radical intermediate (Halliwell and Gutteridge, 2007; Malinski, 2007).”
From The mitochondria-targeted antioxidant MitoQ prevents loss of spatial memory retention and early neuropathology in a transgenic mouse model of Alzheimer’s disease (2011) · cites this paper as Malinski, 2007
An imbalance between protective •NO and highly cytotoxic ONOO− may be crucial in the initial step of development of several vascular and neuronal diseases, including AD.
“An imbalance between protective • NO and highly cytotoxic ONOO -may be crucial in the initial step of the development of several vascular and neuronal diseases, including AD (Malinski, 2007).”
From Multi-target neuroprotective effects of herbal medicines for Alzheimer's disease (2022) · cites this paper as Malinski, 2007
Cites
Alzheimer's disease: the amyloid cascade hypothesis
Hardy, J. A., & Higgins, G. A. (1992) · Science · doi:10.1126/science.1566067 · Cited by 7,484 · see citing works
Alzheimer's Disease: Genes, Proteins, and Therapy
Selkoe, D. J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.741 · Cited by 6,063 · see citing works
Nitric oxide synthases: structure, function and inhibition
ALDERTON, W. K., Cooper, C. E., & Knowles, R. G. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3570593 · Cited by 4,106 · see citing works
Neurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin Neuropeptides
Yankner, B. A., Duffy, L. K., & Kirschner, D. A. (1990) · Science · doi:10.1126/science.2218531 · Cited by 1,975 · see citing works
Widespread Peroxynitrite-Mediated Damage in Alzheimer’s Disease
Smith, M. A., Richey Harris, P. L., Sayre, L. M., Beckman, J. S., & Perry, G. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02653.1997 · Cited by 1,239 · see citing works
Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid β-peptide
Butterfield, D. A., Drake, J., Pocernich, C., & Castegna, A. (2001) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(01)02173-6 · Cited by 1,114 · see citing works
Nitric oxide release from a single cell measured in situ by a porphyrinic-based microsensor
Maliñski, T., & Taha, Z. (1992) · Nature · doi:10.1038/358676a0 · Cited by 1,071 · see citing works
Neurodegenerative diseases and oxidative stress
Emerit, J., Edeas, M. A., & Bricaire, F. (2003) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2003.11.004 · Cited by 1,031 · see citing works
A novel neuronal messenger molecule in brain: The free radical, nitric oxide
Dawson, T. M., Dawson, V. L., & Snyder, S. H. (1992) · Annals of Neurology · doi:10.1002/ana.410320302 · Cited by 834 · see citing works
Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death
Boje, K. M., & Arora, P. K. (1992) · Brain Research · doi:10.1016/0006-8993(92)91004-x · Cited by 786 · see citing works
Evidence that 4-Hydroxynonenal Mediates Oxidative Stress-Induced Neuronal Apoptosis
Kruman, I. I., Bruce‐Keller, A. J., Bredesen, D. E., Waeg, G., & Mattson, M. P. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-13-05089.1997 · Cited by 719 · see citing works
The physiology and pathophysiology of nitric oxide in the brain
Guix, F. X., Uribesalgo, I., Coma, M., & Muñoz, F. J. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.06.001 · Cited by 708 · see citing works
Enhanced Peroxynitrite Formation Is Associated with Vascular Aging
van der Loo, B., Labugger, R., Skepper, J. N., Bachschmid, M. M., Kilo, J., Powell, J. M., Palacios‐Callender, M., Erusalimsky, J. D., Quaschning, T., Maliñski, T., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.12.1731 · Cited by 674 · see citing works
Hensley, K., Maidt, M. L., Yu, Z., Sang, H., Markesbery, W. R., & Floyd, R. A. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-20-08126.1998 · Cited by 508 · see citing works
A selective defect of cytochrome c oxidase is present in brain of Alzheimer disease patients
Maurer, I. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00112-3 · Cited by 475 · see citing works
Alzheimer's disease: the two-hit hypothesis.
Zhu, X.-W., Raina, A., Perry, G., & Smith, M. A. (2004) · Lancet Neurology · doi:10.1016/s1474-4422(04)00707-0 · Cited by 449 · see citing works
Nitric Oxide Signaling Contributes to Late-Phase LTP and CREB Phosphorylation in the Hippocampus
Lü, Y.-F., Kandel, E. R., & Hawkins, R. D. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-23-10250.1999 · Cited by 409 · see citing works
Beltrán, B., Mathur, A., Duchen, M. R., Erusalimsky, J. D., & Moncada, S. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.26.14602 · Cited by 392 · see citing works
The role of oxidative stress in the toxicity induced by amyloid β-peptide in Alzheimer’s disease
Miranda, S., Opazo, C., Larrondo, L. F., Muñoz, F. J., Ruiz, F., Leighton, F., & Inestrosa, N. C. (2000) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00015-0 · Cited by 369 · see citing works
Reddy, P. H. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03530.x · Cited by 356 · see citing works
Caspase-2 Mediates Neuronal Cell Death Induced by β-Amyloid
Troy, C. M., Rabacchi, S. A., Friedman, W., Frappier, T. F., Brown, K. R., & Shelanski, M. L. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-04-01386.2000 · Cited by 354 · see citing works
Tetrahydrobiopterin alters superoxide and nitric oxide release in prehypertensive rats.
Cosentino, F., Patton, S. R., d’Uscio, L. V., Werner, E. R., Werner‐Felmayer, G., Moreau, P. R., Maliñski, T., & Lüscher, T. F. (1998) · Journal of Clinical Investigation · doi:10.1172/jci650 · Cited by 351 · see citing works
Role of nitric oxide, nitroxidative and oxidative stress in wound healing.
Soneja, A., Drews, M., & Maliñski, T. (2005) · PubMed · Cited by 349 · see citing works
Akama, K. T., Albanese, C., Pestell, R. G., & Eldik, L. J. V. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.10.5795 · Cited by 348 · see citing works
Oxidative Stress Signaling in Alzheimers Disease
Su, B., Wang, X., Nunomura, A., Moreira, P., Lee, H.-G., Perry, G., Smith, M., & Zhu, X. (2008) · Current Alzheimer Research · doi:10.2174/156720508786898451 · Cited by 344 · see citing works
Race-Specific Differences in Endothelial Function
Kalinowski, L., Dobrucki, I. T., & Maliñski, T. (2004) · Circulation · doi:10.1161/01.cir.0000129087.81352.7a · Cited by 326 · see citing works
Connelly, L., Palacios‐Callender, M., Ameixa, C., Moncada, S., & Hobbs, A. J. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.6.3873 · Cited by 319 · see citing works
Law, A. (2001) · Brain Research Reviews · doi:10.1016/s0165-0173(00)00051-5 · Cited by 312 · see citing works
Nitric Oxide and Apoptosis: Another Paradigm for the Double-Edged Role of Nitric Oxide
Dimmeler, S., & Zeiher, A. M. (1997) · Nitric Oxide · doi:10.1006/niox.1997.0133 · Cited by 309 · see citing works
Relation of the tocopherol forms to incident Alzheimer disease and to cognitive change
Morris, M. C., Evans, D. A., Tangney, C. C., Bienias, J. L., Wilson, R. S., Aggarwal, N. T., & Scherr, P. A. (2005) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn.81.2.508 · Cited by 302 · see citing works
Cyclic GMP‐Dependent Protein Kinase and Cellular Signaling in the Nervous System
Wang, X., & Robinson, P. J. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68020443.x · Cited by 289 · see citing works
Amyloid β-induced Changes in Nitric Oxide Production and Mitochondrial Activity Lead to Apoptosis
Keil, U., Bonert, A., Marques, C. A., Scherping, I., Weyermann, J., Strosznajder, J. B., Müller-Spahn, F., Haass, C., Czech, C., Pradier, L., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405600200 · Cited by 287 · see citing works
Xie, Z., Wei, M., Morgan, T. E., Fabrizio, P., Han, D., Finch, C. E., & Longo, V. D. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-09-03484.2002 · Cited by 272 · see citing works
Gupta, T. K., Törüner, M., & Groszmann, R. J. (1998) · Digestion · doi:10.1159/000007500 · Cited by 260 · see citing works
Presenilins, the Endoplasmic Reticulum, and Neuronal Apoptosis in Alzheimer's Disease
Mattson, M. P., Guo, Q., Furukawa, K., & Pedersen, W. A. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70010001.x · Cited by 246 · see citing works
Rogers, J., & Lue, L.-F. (2001) · Neurochemistry International · doi:10.1016/s0197-0186(01)00040-7 · Cited by 236 · see citing works
Mechanical Transduction of Nitric Oxide Synthesis in the Beating Heart
Pinsky, D. J., Patton, S. R., Mesároš, Š., Brovkovych, V. M., Kubaszewski, E., Grunfeld, S., & Maliñski, T. (1997) · Circulation Research · doi:10.1161/01.res.81.3.372 · Cited by 233 · see citing works
Huk, I., Nanobashvili, J., Neumayer, C., Punz, A., Mueller, M., Afkhampour, K., Mittlboeck, M., Losert, U. M., Polterauer, P., Roth, E., et al. (1997) · Circulation · doi:10.1161/01.cir.96.2.667 · Cited by 232 · see citing works
Kim, Y., Chung, H., Kim, S. S., Han, J., Yoo, Y., Kim, K.-M., Lee, G., Yun, H., Green, A., Li, J., et al. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-16-06740.1999 · Cited by 224 · see citing works
Vergnani, L., Hatrik, S., Ricci, F., Passaro, A., Manzoli, N., Zuliani, G., Brovkovych, V. M., Fellin, R., & Maliñski, T. (2000) · Circulation · doi:10.1161/01.cir.101.11.1261 · Cited by 219 · see citing works
Nitric Oxide Synthase Activity Is Elevated in Brain Microvessels in Alzheimer′s Disease
Dorheim, M. A., Tracey, W. R., Pollock, J. S., & Grammas, P. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.2716 · Cited by 216 · see citing works
Nitric oxide synthases: targets for therapeutic strategies in neurological diseases
Chabrier, P. E., Demerlé-Pallardy, C., & Auguet, M. (1999) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050353 · Cited by 215 · see citing works
Mason, R. P., Kalinowski, L., Jacob, R. F., Jacoby, A. M., & Maliñski, T. (2005) · Circulation · doi:10.1161/circulationaha.105.556233 · Cited by 194 · see citing works
Nitric oxide and neurological disorders
Duncan, A., & Heales, S. (2005) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2004.09.004 · Cited by 189 · see citing works
Springer, J. E., Azbill, R. D., Mark, R. J., Begley, J. G., Waeg, G., & Mattson, M. P. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68062469.x · Cited by 188 · see citing works
Direct measurement of nitric oxide in human beings
Vallance, P. J., Bhagat, K., MacAllister, R. J., Patton, S. R., Maliñski, T., Radomski, M. W., & Moncada, S. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91211-8 · Cited by 169 · see citing works
Quantitation of 8-Oxoguanine and Strand Breaks Produced by Four Oxidizing Agents
Kennedy, L. J., Moore, K., Caulfield, J. L., Tannenbaum, S. R., & Dedon, P. C. (1997) · Chemical Research in Toxicology · doi:10.1021/tx960102w · Cited by 169 · see citing works
Mitochondrial enzyme-deficient hippocampal neurons and choroidal cells in AD
Cottrell, D. A., Blakely, E. L., Johnson, M. A., Ince, P. G., & Turnbull, D. M. (2001) · Neurology · doi:10.1212/wnl.57.2.260 · Cited by 163 · see citing works
Begley, J. G., Duan, W., Chan, S. L., Duff, K., & Mattson, M. P. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0721030.x · Cited by 157 · see citing works
Prickaerts, J., Steinbusch, H. W. M., Smits, J. F. M., & de Vente, J. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01301-0 · Cited by 156 · see citing works
Tong, X., Nicolakakis, N., Kocharyan, A., & Hamel, É. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.4031-05.2005 · Cited by 153 · see citing works
Butterfield, D. A. (2003) · Current Medicinal Chemistry · doi:10.2174/0929867033456422 · Cited by 149 · see citing works
Oxidative Imbalance in Alzheimer's Disease
Zhu, X., Lee, H., Casadesús, G., Ávila, J., Drew, K. L., Perry, G. L., & Smith, M. A. (2005) · Molecular Neurobiology · doi:10.1385/mn:31:1-3:205 · Cited by 146 · see citing works
Shacter, E. B. (2000) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(00)19040-8 · Cited by 144 · see citing works
Viña, J. (2004) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2004.02.013 · Cited by 142 · see citing works
Kalinowski, L., Dobrucki, L. W., Brovkovych, V. M., & Maliñski, T. (2002) · Circulation · doi:10.1161/hc0802.104283 · Cited by 134 · see citing works
The Nitration Product 5-Nitro-γ-tocopherol Is Increased in the Alzheimer Brain
Williamson, K. S., Gabbita, S. P., Mou, S., West, M. S., Pye, Q. N., Markesbery, W. R., Cooney, R. V., Grammas, P., Reimann‐Philipp, U., Floyd, R. A., et al. (2002) · Nitric Oxide · doi:10.1006/niox.2001.0399 · Cited by 130 · see citing works
The Specific Role of cGMP in Hippocampal LTPPreprint
Son, H., Lü, Y.-F., Zhuo, M., Arancio, O., Kandel, E. R., & Hawkins, R. D. (1998) · Learning & Memory · doi:10.1101/lm.5.3.231 · Cited by 129 · see citing works
Nitric oxide changes in the rat brain after transient middle cerebral artery occlusion
Zhang, Z. G., Chopp, M., Bailey, F., & Maliñski, T. (1995) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(94)00216-b · Cited by 127 · see citing works
Blatter, L. A., Taha, Z., Mesároš, Š., Shacklock, P. S., Wier, W. G., & Maliñski, T. (1995) · Circulation Research · doi:10.1161/01.res.76.5.922 · Cited by 116 · see citing works
Reactive Oxygen and Nitrogen Species in Alzheimers Disease
Aslan, M., & Özben, T. (2004) · Current Alzheimer Research · doi:10.2174/1567205043332162 · Cited by 97 · see citing works
Microglial Contribution to Oxidative Stress in Alzheimer's Disease
Colton, C. A., Chernyshev, O. N., Gilbert, D. L., & Vitek, M. P. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06195.x · Cited by 94 · see citing works
Hallström, S., Gasser, H., Neumayer, C., Fügl, A., Nanobashvili, J., Jakubowski, A., Huk, I., Schlag, G., & Maliñski, T. (2002) · Circulation · doi:10.1161/01.cir.0000018745.11739.9b · Cited by 93 · see citing works
Zingerone as an Antioxidant against Peroxynitrite
Shin, S.-G., Kim, J. Y., Chung, H. Y., & Jeong, J. (2005) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf051014x · Cited by 92 · see citing works
Estévez, Á. G., Spear, N., Manuel, S. M., Barbeito, L., Radí, R., & Beckman, J. S. (1998) · Progress in brain research · doi:10.1016/s0079-6123(08)63214-8 · Cited by 91 · see citing works
Kalinowski, L., & Maliñski, T. (2004) · Acta Biochimica Polonica · doi:10.18388/abp.2004_3584 · Cited by 88 · see citing works
Understanding Nitric Oxide Physiology in the Heart: A Nanomedical Approach
Maliñski, T. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.07.029 · Cited by 77 · see citing works
Paxinou, E., Weisse, M., Chen, Q., Souza, J. M., Hertkorn, C., Selak, M. A., Daikhin, E., Yudkoff, M., Sowa, G., Sessa, W. C., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.201293198 · Cited by 77 · see citing works
Norris, P. J., Faull, R. L. M., & Emson, P. C. (1996) · Molecular Brain Research · doi:10.1016/0169-328x(96)00064-2 · Cited by 75 · see citing works
Gibson, G. (2002) · Free Radical Biology & Medicine · doi:10.1016/s0891-5849(02)00802-x · Cited by 74 · see citing works
Amyloid β peptides mediate hypoxic augmentation of Ca2+ channels
Green, K. N., & Peers, C. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00338.x · Cited by 74 · see citing works
Oxidative stress in mild cognitive impairment and Alzheimer disease: A continuum
Mecocci, P. (2004) · Journal of Alzheimer s Disease · doi:10.3233/jad-2004-6207 · Cited by 70 · see citing works
Preparation and optimization of superoxide microbiosensor
Mesároš, Š., Vaňková, Ž., Grunfeld, S., Mesárošová, A., & Maliñski, T. (1998) · Analytica Chimica Acta · doi:10.1016/s0003-2670(97)00589-8 · Cited by 69 · see citing works
Nitric oxide synthase neurons in different areas of normal aged and Alzheimer's brains
Yew, D. T. W., Wong, H. W., Li, W., Lai, H. W. L., & Yu, W.-H. A. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00383-2 · Cited by 61 · see citing works
Meier‐Ruge, W., & Bertoni–Freddari, C. (1996) · Reviews in the Neurosciences · doi:10.1515/revneuro.1996.7.1.1 · Cited by 59 · see citing works
Nitric Oxide Mimetic Molecules as Therapeutic Agents in Alzheimers Disease
Thatcher, G. R. J., Bennett, B. M., & Reynolds, J. N. (2005) · Current Alzheimer Research · doi:10.2174/1567205053585945 · Cited by 56 · see citing works
Chung, A. W. Y., Radomski, A. S., Alonso‐Escolano, D., Jurasz, P., Stewart, M. W., Maliñski, T., & Radomski, M. W. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705997 · Cited by 55 · see citing works
Zandi, P. P. (2004) · Archives of Neurology · doi:10.1001/archneur.61.1.82 · Cited by 47 · see citing works
Nitric oxide release from normal and dysfunctional endothelium.
Brovkovych, V. M., Dobrucki, L. W., Brovkovych, S. D., Dobrucki, I. T., Nascimento, C. A. D., Burewicz, A., & Malinski, T. (1999) · PubMed · Cited by 42 · see citing works
Self-citationIschemia/reperfusion injury of skeletal muscle: Plasma taurine as a measure of tissue damage
Nanobashvili, J., Neumayer, C., Fügl, A., Punz, A., Blumer, R., Prager, M., Mittlböck, M., Gruber, H., Polterauer, P., Roth, E., et al. (2003) · Surgery · doi:10.1067/msy.2003.65 · Cited by 41 · see citing works
Strategies That Support Declining Cholinergic Neurotransmission in Alzheimer’s Disease Patients
Sirviö, J. (1999) · Gerontology · doi:10.1159/000052759 · Cited by 40 · see citing works
Nanobashvili, J., Neumayer, C., Fügl, A., Punz, A., Blumer, R., Mittlböck, M., Prager, M., Polterauer, P., Dobrucki, L. W., Huk, I., et al. (2004) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2003.10.060 · Cited by 31 · see citing works
The protective role of nitric oxide in the brain ischemia.
Dobrucki, L. W., Kalinowski, L., Uracz, W., & Maliñski, T. (2000) · PubMed · Cited by 22 · see citing works
Nitric Oxide Deficiency Contributes to Large Cerebral Infarct Size
Kidd, G. A., Dobrucki, L. W., Brovkovych, V. M., Bohr, D. F., & Maliñski, T. (2000) · Hypertension · doi:10.1161/01.hyp.35.5.1111 · Cited by 21 · see citing works
Central Hypotensive Action of Clonidine Requires Nitric Oxide
Dobrucki, L. W., Cabrera, C., Bohr, D. F., & Maliñski, T. (2001) · Circulation · doi:10.1161/hc4101.098281 · Cited by 18 · see citing works
Gargiulo, L., Bermejo, M., & Liras, A. (2000) · Revista de Neurología · doi:10.33588/rn.3004.99196 · Cited by 14 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Excited-state intramolecular proton-transfer (ESIPT) based fluorescence sensors and imaging agents
Sedgwick, A. C., Wu, L., Han, H., Bull, S. D., He, X., James, T. D., Sessler, J. L., Tang, B. Z., Tian, H., & Yoon, J. (2018) · Chemical Society Reviews · doi:10.1039/c8cs00185e · Cited by 1,577 · see citing works
Fricker, M., Tolkovsky, A. M., Borutaitė, V., Coleman, M. P., & Brown, G. C. (2018) · Physiological Reviews · doi:10.1152/physrev.00011.2017 · Cited by 1,122 · see citing works
A review on cholinesterase inhibitors for Alzheimer’s disease
Anand, P., & Singh, B. (2013) · Archives of Pharmacal Research · doi:10.1007/s12272-013-0036-3 · Cited by 722 · see citing works
Zhou, L., & Zhu, D. (2009) · Nitric Oxide · doi:10.1016/j.niox.2009.03.001 · Cited by 659 · see citing works
Therapeutic applications of compounds in the Magnolia family
Lee, Y., Lee, Y. M., Lee, C., Jung, J., Han, S., & Hong, J. T. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.01.010 · Cited by 490 · see citing works
McManus, M. J., Murphy, M. P., & Franklin, J. L. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.0552-11.2011 · Cited by 432 · see citing works
Neuroprotective strategies involving ROS in Alzheimer disease
Dumont, M., & Beal, M. F. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.11.026 · Cited by 402 · see citing works
Biomarkers in Stress Related Diseases/Disorders: Diagnostic, Prognostic, and Therapeutic Values
Dhama, K., Latheef, S. K., Dadar, M., Samad, H. A., Munjal, A. K., Khandia, R., Karthik, K., Tiwari, R., Yatoo, M. I., Bhatt, P., et al. (2019) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2019.00091 · Cited by 333 · see citing works
Microbiota from young mice counteracts selective age-associated behavioral deficits
Boehme, M., Guzzetta, K. E., Bastiaanssen, T. F. S., van de Wouw, M., Moloney, G. M., Gual-Grau, A., Spichak, S., Olavarría-Ramírez, L., Fitzgerald, P., Morillas, E., et al. (2021) · Nature Aging · doi:10.1038/s43587-021-00093-9 · Cited by 313 · see citing works
Advances in developing novel therapeutic strategies for Alzheimer’s disease
Cao, J., Hou, J., Ping, J., & Cai, D. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0299-8 · Cited by 283 · see citing works
Targeting neuroinflammation in Alzheimer’s disease
Bronzuoli, M. R., Iacomino, A., Steardo, L., & Scuderi, C. (2016) · Journal of Inflammation Research · doi:10.2147/jir.s86958 · Cited by 255 · see citing works
Biomarkers of oxidative and nitrosative damage in Alzheimer's disease and mild cognitive impairment
Mangialasche, F., Polidori, M. C., Monastero, R., Ercolani, S., Camarda, C., Cecchetti, R., & Mecocci, P. (2009) · Ageing Research Reviews · doi:10.1016/j.arr.2009.04.002 · Cited by 247 · see citing works
Vukic, V., Callaghan, D., Walker, D., Lue, L.-F., Liu, Q. Y., Couraud, P.-O., Romero, I. A., Weksler, B., Stanimirovic, D. B., & Zhang, W. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.12.007 · Cited by 232 · see citing works
Fluorescent Diagnostic Probes in Neurodegenerative Diseases
Zhou, J., Jangili, P., Son, S., Ji, M. S., Won, M., & Kim, J. S. (2020) · Advanced Materials · doi:10.1002/adma.202001945 · Cited by 206 · see citing works
An ESIPT Probe for the Ratiometric Imaging of Peroxynitrite Facilitated by Binding to Aβ-Aggregates
Sedgwick, A. C., Dou, W., Jiao, J., Wu, L., Williams, G. T., Jenkins, A. T. A., Bull, S. D., Sessler, J. L., He, X., & James, T. D. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.8b08457 · Cited by 205 · see citing works
Eradication of Helicobacter pylori may be beneficial in the management of Alzheimer’s disease
Kountouras, J., Boziki, M. K., Gavalas, E., Zavos, C., Grigoriadis, N., Deretzi, G., Tzilves, D., Katsinelos, P., Tsolaki, M., Chatzopoulos, D., et al. (2009) · Journal of Neurology · doi:10.1007/s00415-009-5011-z · Cited by 190 · see citing works
Altered arginine metabolism in Alzheimer's disease brains
Liu, P., Fleete, M. S., Yu, J., Collie, N. D., Curtis, M. A., Waldvogel, H. J., Faull, R. L. M., Abraham, W. C., & Zhang, H. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.03.013 · Cited by 186 · see citing works
Mitochondrial dysfunction and cell death in neurodegenerative diseases through nitroxidative stress
Akbar, M. D., Essa, M. M., Daradkeh, G., Abdelmegeed, M. A., Choi, Y., Mahmood, L., & Song, B. (2016) · Brain Research · doi:10.1016/j.brainres.2016.02.016 · Cited by 176 · see citing works
Alhasson, F. A., Das, S., Seth, R. K., Dattaroy, D., Chandrashekaran, V., Ryan, C. N., Chan, L. S., Testerman, T. L., Burch, J. B., Hofseth, L. J., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0172914 · Cited by 152 · see citing works
Dong, Y., Kataoka, K., Tokutomi, Y., Nako, H., Nakamura, T., Toyama, K., Sueta, D., Koibuchi, N., Yamamoto, E., Ogawa, H., et al. (2011) · The FASEB Journal · doi:10.1096/fj.11-182873 · Cited by 142 · see citing works
Getting to NO Alzheimer’s Disease: Neuroprotection versus Neurotoxicity Mediated by Nitric Oxide
Balez, R., & Ooi, L. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/3806157 · Cited by 138 · see citing works
Primary Cerebral Blood Flow Deficiency and Alzheimer's Disease: Shadows and Lights
Mazza, M., Marano, G., Traversi, G., Bria, P., & Mazza, S. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-090700 · Cited by 129 · see citing works
Blood-brain barrier integrity in the pathogenesis of Alzheimer’s disease
Huang, Z., Wong, L., Su, Y., Huang, X., Wang, N., Chen, H., & Yi, C. (2020) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2020.100857 · Cited by 130 · see citing works
Butterfield, D. A., Reed, T. T., & Rukhsana Sultana, A. (2010) · Free Radical Research · doi:10.3109/10715762.2010.520014 · Cited by 123 · see citing works
Nitric Oxide Donors as Neuroprotective Agents after an Ischemic Stroke-Related Inflammatory Reaction
Godínez-Rubí, M., Rojas-Mayorquín, A. E., & Ortuño‐Sahagún, D. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/297357 · Cited by 122 · see citing works
Glial Tau Pathology in Tauopathies: Functional Consequences
Kahlson, M. A., & Colodner, K. J. (2015) · Journal of Experimental Neuroscience · doi:10.4137/jen.s25515 · Cited by 110 · see citing works
L-Arginine and Nitric Oxide in CNS Function and Neurodegenerative Diseases
Virarkar, M., Alappat, L., Bradford, P. G., & Awad, A. B. (2013) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2011.573885 · Cited by 104 · see citing works
Hydrogen sulfide, nitric oxide, and neurodegenerative disorders
Panthi, S., Manandhar, S., & Gautam, K. (2018) · Translational Neurodegeneration · doi:10.1186/s40035-018-0108-x · Cited by 100 · see citing works
Neurotrophic and Neuroprotective Effects of Hericium erinaceus
Szućko-Kociuba, I., Trzeciak-Ryczek, A., Kupnicka, P., & Chlubek, D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242115960 · Cited by 98 · see citing works
Kim, C., Lee, C., Park, G. H., & Jang, J.-H. (2009) · Archives of Pharmacal Research · doi:10.1007/s12272-009-1609-z · Cited by 96 · see citing works
The Effects of NOS2 Gene Deletion on Mice Expressing Mutated Human AβPP
Colton, C. A., Wilcock, D. M., Wink, D. A., Davis, J., Nostrand, W. E. V., & Vitek, M. P. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-15405 · Cited by 92 · see citing works
Development of novel phosphodiesterase 5 inhibitors for the therapy of Alzheimer’s disease
Zuccarello, E., Acquarone, E., Calcagno, E., Argyrousi, E. K., Deng, S., Landry, D. W., Arancio, O., & Fiorito, J. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.113818 · Cited by 93 · see citing works
Treatment of Alzheimer’s Disease with a Cholinesterase Inhibitor Combined with Antioxidants
Cornelli, U. (2010) · Neurodegenerative Diseases · doi:10.1159/000295663 · Cited by 90 · see citing works
JIANG, P., Li, C., Xiang, Z., & Jiao, B. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2254 · Cited by 89 · see citing works
Cigliano, L., Spagnuolo, M. S., Crescenzo, R., Cancelliere, R., Iannotta, L., Mazzoli, A., Liverini, G., & Iossa, S. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0518-2 · Cited by 89 · see citing works
Lourenço, C. F., Ledo, A., Barbosa, R. M., & Laranjinha, J. A. N. (2017) · Experimental Neurology · doi:10.1016/j.expneurol.2017.01.013 · Cited by 84 · see citing works
L-arginine and Alzheimer's disease.
Yi, J., Horky, L. L., Friedlich, A. L., Shi, Y., Rogers, J. T., & Huang, X. (2009) · PubMed Central · Cited by 83 · see citing works
Overlapped Metabolic and Therapeutic Links between Alzheimer and Diabetes
Ahmad, W. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8352-z · Cited by 80 · see citing works
Conformational Altered p53 as an Early Marker of Oxidative Stress in Alzheimer's Disease
Buizza, L., Cenini, G., Lanni, C., Ferrari‐Toninelli, G., Prandelli, C., Govoni, S. M., Buoso, E., Racchi, M., Barcikowska, M., Styczyńska, M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029789 · Cited by 81 · see citing works
Redox and Nitric Oxide-Mediated Regulation of Sensory Neuron Ion Channel Function
Gamper, N. L., & Ooi, L. (2014) · Antioxidants and Redox Signaling · doi:10.1089/ars.2014.5884 · Cited by 79 · see citing works
Chaouch, M. A., Hafsa, J., Rihouey, C., Cerf, D. L., & Majdoub, H. (2015) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2015.06.003 · Cited by 75 · see citing works
Research progress of multi-functional fluorescent probes for Alzheimer's disease monitoring
Yang, J., Guo, Y., Pistolozzi, M., & Yan, J. (2021) · Dyes and Pigments · doi:10.1016/j.dyepig.2021.109466 · Cited by 74 · see citing works
Díaz, A., Limón, I. D., Chávez, R., Zenteno, E., & Guevara, J. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-111979 · Cited by 73 · see citing works
Furini, C. R., Rossato, J. I., Bitencourt, L. L., Medina, J. H., Izquierdo, I., & Cammarota, M. (2010) · Hippocampus · doi:10.1002/hipo.20656 · Cited by 72 · see citing works
Song, B.-J., Abdelmegeed, M. A., Henderson, L. E., Yoo, S.-H., Wan, J., Purohit, V., Hardwick, J. P., & Moon, K.-H. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/781050 · Cited by 67 · see citing works
Quintanilla, R. A., Orellana, J. A., & Rommy von Bernhardi, M. (2012) · Archives of Medical Research · doi:10.1016/j.arcmed.2012.10.016 · Cited by 65 · see citing works
Gong, Y., Huang, A., Guo, X., Zhi, J., Chen, X., Zhu, X., Xia, Y., Liu, J., Xu, Y., & Qin, X. (2021) · Chemical Engineering Journal · doi:10.1016/j.cej.2021.129345 · Cited by 63 · see citing works
Metformin prevents p-tau and amyloid plaque deposition and memory impairment in diabetic mice
Oliveira, W. H., Braga, C. F., Lós, D. B., Araújo, S. M. R., França, M. R., Duarte-Silva, E., Rodrigues, G. B., Rocha, S. W. S., & Peixoto, C. A. (2021) · Experimental Brain Research · doi:10.1007/s00221-021-06176-8 · Cited by 64 · see citing works
Age-related changes in arginine and its metabolites in memory-associated brain structures
Liu, P., Yu, J. H., & Zhang, H. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.08.029 · Cited by 64 · see citing works
The in silico and in vivo evaluation of puerarin against Alzheimer's disease
Liu, S., Cao, X., Liu, G.-Q., Zhou, T., Yang, X., & Ma, B.-X. (2019) · Food & Function · doi:10.1039/c8fo01696h · Cited by 62 · see citing works
Ali, M. R. A., Abo‐Youssef, A. M., Messiha, B. A. S., & Khattab, M. M. (2016) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-016-1234-6 · Cited by 62 · see citing works
Oh, J. H., Kang, L. L., Ban, J. O., Kim, Y. H., Kim, K. H., Han, S., & Hong, J. T. (2009) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2009.03.014 · Cited by 61 · see citing works
Taupin, P. (2009) · Current Alzheimer Research · doi:10.2174/156720509790147151 · Cited by 59 · see citing works
Gałecki, P., Maes, M. H. J., Florkowski, A., Lewiñski, A., Gałecka, E., Bieńkiewicz, M., & Szemraj, J. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.09.005 · Cited by 59 · see citing works
Nitric oxide mediates glial-induced neurodegeneration in Alexander disease
Wang, L., Hagemann, T. L., Kalwa, H., Michel, T. M., Messing, A., & Feany, M. Β. (2015) · Nature Communications · doi:10.1038/ncomms9966 · Cited by 59 · see citing works
Díaz, A., Mendieta, L., Zenteno, E., Guevara, J., & Limón, I. D. (2010) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2010.12.005 · Cited by 53 · see citing works
Malar, D. S., Shafreen, R. B., Pandian, S. K., & Devi, K. P. (2016) · Pharmaceutical Biology · doi:10.1080/13880209.2016.1241811 · Cited by 51 · see citing works
Hajjo, R., Sabbah, D. A., Abusara, O. H., & Bawab, A. Q. A. (2022) · Diagnostics · doi:10.3390/diagnostics12122975 · Cited by 55 · see citing works
He, X.-L., Zhou, W.-Q., Ming-gang, B., & Du, G. (2010) · Brain Research · doi:10.1016/j.brainres.2010.03.084 · Cited by 50 · see citing works
Bergin, D., Yu, J. H., Mockett, B., Zhang, H., Abraham, W. C., & Liu, P. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0149-z · Cited by 50 · see citing works
Nadiga, A. P. R., Suman, & Krishna, K. L. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176332 · Cited by 48 · see citing works
Jung, Y.-S., Kim, D. H., Hwang, J. Y., Yun, N. Y., Lee, Y.-H., Han, S., Hwang, B. Y., Lee, M. S., Jeong, H. S., & Hong, J. T. (2014) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2014.03.001 · Cited by 46 · see citing works
Autotaxin protects microglial cells against oxidative stress
Awada, R., Rondeau, P., Grès, S., Saulnier‐Blache, J. S., d’Hellencourt, C. L., & Bourdon, E. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.11.014 · Cited by 46 · see citing works
Multi-target neuroprotective effects of herbal medicines for Alzheimer's disease
Fernandes, F., Barroso, M. F., De Simone, A., Emriková, E., Dias-Teixeira, M., Pereira, J. P., Chlebek, J., Fernandes, V. C., Rodrigues, F., Andrisano, V., et al. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115107 · Cited by 45 · see citing works
Neurovascular coupling in Alzheimer patients: Effect of acetylcholine-esterase inhibitors
Rosengarten, B., Paulsen, S., Burr, O., & Kaps, M. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.02.017 · Cited by 43 · see citing works
S-Nitrosylation of ApoE in Alzheimer’s Disease
Abrams, A. J., Farooq, A., & Wang, G. (2011) · Biochemistry · doi:10.1021/bi200266v · Cited by 43 · see citing works
Zhang, X., Wang, B., Xiao, Y., Wang, C., & He, L. (2018) · The Analyst · doi:10.1039/c8an00905h · Cited by 42 · see citing works
Fernando, C. D., & Soysa, P. (2014) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-14-395 · Cited by 41 · see citing works
Lou, G., ZHANG, Q.-H., Xiao, F., Xiang, Q., Su, Z., Zhang, L., Yang, P., Yang, Y. F., Zheng, Q., & Huang, Y. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.08.003 · Cited by 40 · see citing works
Ageing alters behavioural function and brain arginine metabolism in male Sprague–Dawley rats
Gupta, N. K., Yu, J. H., Collie, N. D., Zhang, H., & Liu, P. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.09.013 · Cited by 40 · see citing works
Pre-aggregated Aβ25–35 alters arginine metabolism in the rat hippocampus and prefrontal cortex
Liu, P., Yu, J. H., Collie, N. D., Campbell, S. A., & Zhang, H. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.07.054 · Cited by 40 · see citing works
Zaręba-Kozioł, M., Szwajda, A., Dadlez, M., Wysłouch-Cieszyńska, A., & Lalowski, M. (2014) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m113.036079 · Cited by 39 · see citing works
“(RNS) play a crucial role in these processes (38).”
BackgroundPang, H.-Y., Liu, G., & Liu, G.-T. (2009) · Acta Pharmacologica Sinica · doi:10.1038/aps.2008.29 · Cited by 39 · see citing works
Manukhina, E. B., Goryacheva, A. V., Barskov, I. V., Викторов, И. В., Guseva, A. A., Pshennikova, M. G., Khomenko, I. P., Mashina, S. Y., Pokidyshev, D. A., & Malyshev, I. Y. (2010) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-010-9320-6 · Cited by 39 · see citing works
Heme oxygenase-1 derived carbon monoxide suppresses Aβ1–42 toxicity in astrocytes
Hettiarachchi, N. T., Boyle, J. P., Dallas, M. L., Al‐Owais, M. M., Scragg, J. L., & Peers, C. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.276 · Cited by 38 · see citing works
Alzheimer’s Disease: A Contextual Link with Nitric Oxide Synthase
Dubey, H., Gulati, K., & Ray, A. (2019) · Current Molecular Medicine · doi:10.2174/1566524019666191129103117 · Cited by 38 · see citing works
Rushaidhi, M., Yu, J. H., Kennard, J. T., Collie, N. D., Williams, J. M., Zhang, H., & Liu, P. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.02.021 · Cited by 38 · see citing works
McCarty, M. F., Barroso-Aranda, J., & Contreras, F. (2009) · Medical Hypotheses · doi:10.1016/j.mehy.2008.09.058 · Cited by 38 · see citing works
Effects of prolonged agmatine treatment in aged male Sprague–Dawley rats
Rushaidhi, M., Zhang, H., & Liu, P. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.01.004 · Cited by 37 · see citing works
Role of Arginine Guanidinium Moiety in Nitric-oxide Synthase Mechanism of Oxygen Activation
Giroud, C., Moreau, M., Mattioli, T. A., Balland, V., Boucher, J., Li, Y., Stuehr, D. J., & Santolini, J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.038240 · Cited by 37 · see citing works
Hoos, M. D., Vitek, M. P., Ridnour, L. A., Wilson, J. G., Jansen, M., Everhart, A. L., Wink, D. A., & Colton, C. A. (2014) · Molecular Neurodegeneration · doi:10.1186/1750-1326-9-50 · Cited by 35 · see citing works
Divergence in the metabolome between natural aging and Alzheimer’s disease
Hunsberger, H. C., Greenwood, B. P., Tolstikov, V., Narain, N. R., Kiebish, M. A., & Denny, C. A. (2020) · Scientific Reports · doi:10.1038/s41598-020-68739-z · Cited by 36 · see citing works
Rodkin, S., Nwosu, C., Sannikov, A., Tyurin, A. V., Чулков, В. С., Raevskaya, M., Ermakov, A. M., Kirichenko, E. Y., & Гасанов, М. З. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076014 · Cited by 39 · see citing works
Age-Related Neurochemical Changes in the Vestibular Nuclei
Smith, P. F. (2016) · Frontiers in Neurology · doi:10.3389/fneur.2016.00020 · Cited by 35 · see citing works
Zhu, G., Guo, M., Zhao, J., Zhang, H., Wang, G., & Chen, W. (2022) · Nutrients · doi:10.3390/nu14040735 · Cited by 35 · see citing works
Parwani, L., Bhatnagar, M., Bhatnagar, A., & Sharma, V. (2013) · Journal of Applied Phycology · doi:10.1007/s10811-013-0180-7 · Cited by 34 · see citing works
Chaouch, M. A., Hafsa, J., Rihouey, C., Cerf, D. L., & Majdoub, H. (2015) · Journal of Food Biochemistry · doi:10.1111/jfbc.12220 · Cited by 34 · see citing works
Kim, S.-J., Lim, J., Kang, S.-K., Lee, Y.-S., & Kang, K. (2008) · Cell Research · doi:10.1038/cr.2008.48 · Cited by 34 · see citing works
M, R. D. S., & P, K. M. P. (2015) · Journal of Nutrition & Food Sciences · doi:10.4172/2155-9600.1000415 · Cited by 33 · see citing works
Pretorius, L., Kell, D. B., & Pretorius, E. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00851 · Cited by 36 · see citing works
Hariharan, A., Yu, J., Collie, N. D., Zhang, H., & Liu, P. (2019) · Nitric Oxide · doi:10.1016/j.niox.2019.03.006 · Cited by 32 · see citing works
Therapeutic Potential of Multifunctional Derivatives of Cholinesterase Inhibitors
Przybyłowska, M., Dzierzbicka, K., Kowalski, S., Chmielewska, K., & Inkielewicz‐Stępniak, I. (2020) · Current Neuropharmacology · doi:10.2174/1570159x19666201218103434 · Cited by 31 · see citing works
The Monkey Head Mushroom and Memory Enhancement in Alzheimer’s Disease
Yanshree, Yu, W. S., Fung, M., Lee, C. W., Lim, L. W., & Wong, K.-H. (2022) · Cells · doi:10.3390/cells11152284 · Cited by 31 · see citing works
Scopolamine impairs behavioural function and arginine metabolism in the rat dentate gyrus
Knox, L. T., Yu, J. H., Fleete, M. S., Collie, N. D., Zhang, H., & Liu, P. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.08.042 · Cited by 30 · see citing works
Liu, P., Zhang, H., Devaraj, R., Ganesalingam, G. S., & Smith, P. F. (2010) · Hearing Research · doi:10.1016/j.heares.2010.06.019 · Cited by 30 · see citing works
Zhao, J., Cheng, Y., Yang, C., Lau, S., Lao, L., Shuai, B., Cai, J., & Rong, J. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9195-1 · Cited by 30 · see citing works
Feng, L., Yang, N., Li, C., Tian, G., Wang, J., Dong, Z.-B., Jia, X., & Di, L. (2017) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2017.07.009 · Cited by 29 · see citing works
Agmatine selectively improves behavioural function in aged male Sprague–Dawley rats
Rushaidhi, M., Collie, N. D., Zhang, H., & Liu, P. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.05.015 · Cited by 29 · see citing works
Nitrative Stress in Cerebral Endothelium is Mediated by mGluR5 in Hyperhomocysteinemia
Mayo, J. N., Beard, R. S., Price, T. O., Chen, C.-H., Erickson, M. A., Nuran Ercal, A., Banks, W. A., & Bearden, S. E. (2011) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2011.185 · Cited by 28 · see citing works
Meiller, A., Sequeira, E., & Marinesco, S. (2019) · Analytical Chemistry · doi:10.1021/acs.analchem.9b03621 · Cited by 28 · see citing works
- Authors
- Malinski, T.
- Affiliations
- Department of Chemistry and Biochemistry Ohio University, 350 W. State Street, Athens, OH 45701, USA. Tel.: ; E-mail: malinski@ohio.edu
- Venue
- Journal of Alzheimer s Disease
- Publisher
- SAGE Publications
- Published
- 2007-05-08
- Volume
- 11
- Issue
- 2
- Pages
- 207-218
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- OpenAlex
- W1690235847
- Cited by
- 220
- References
- 86
- Citations by year
- 2026: 5 · 2025: 8 · 2024: 8 · 2023: 14 · 2022: 17 · 2021: 12 · 2020: 13 · 2019: 13 · 2018: 15 · 2017: 9 · 2016: 8 · 2015: 9 · 2014: 10 · 2013: 14 · 2012: 10
- FWCI
- 9.35
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Alzheimer s Disease (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Physiology › Nitric Oxide and Endothelin Effects
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Keywords
- nitric oxide, nitro-oxidative stress
- MeSH terms
- Alzheimer Disease, Humans, Neurons, Nitric Oxide, Amyloid beta-Peptides, Apoptosis, Reactive Oxygen Species, Oxidative Stress, Dexfenfluramine, Peroxynitrous Acid, Endothelial Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review